ENTITY
CSL Ltd

CSL Ltd (CSL AU)

120
Analysis
Health CareAustralia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
bullishTerumo Corp
23 May 2024 22:41

Terumo Corp (4543 JP): Q4 Result Beats Guidance; Double-Digit Profit Growth to Continue in FY25

​Terumo reported 18% revenue growth in Q4FY24, with operating profit up 45%. FY25 outlook includes revenue of ¥980B, op. profit of ¥165B, and net...

Logo
324 Views
Share
01 Apr 2024 05:00

Australia Short Interest (Q1 2024): A Recap

Total short interest in Australia is A$34.46bn and has decreased by A$1.36bn since the start of the year. We look at the stocks with the largest...

Logo
350 Views
Share
29 Mar 2024 10:19

ASX Short Interest Weekly (Mar 22nd): Rio Tinto, Webjet, Xero, CSL, Westpac, Macquarie

We analyzed ASX short interest report for the past week and highlight short interest changes in Rio Tinto, Webjet, Xero, CSL, Westpac, Macquarie,...

Logo
501 Views
Share
22 Mar 2024 10:09

ASX Short Interest Weekly (Mar 15th): CSL, Paladin Energy, Macquarie, Emerald Resource

We analyzed ASX short interest report for the past week and highlight short interest changes in CSL, Paladin Energy, Macquarie, Emerald Resource,...

Logo
369 Views
Share
15 Mar 2024 06:00

ASX Short Interest Weekly (Mar 8th): ANZ, BHP, IDP Education, Woodside Energy, Macquarie, CSL

We analyzed ASX short interest report for the past week and highlight short interest changes in ANZ, BHP, IDP Education, Woodside Energy,...

Logo
452 Views
Share
x